Nasal IntubationNCT00400972
Comparison of GlideScope Videolaryngoscopy to Direct Laryngoscopy for Nasal Intubation
A study testing GlideScope videolaryngoscope in people with Nasal Intubation, run by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's at 1 site in Canada.
Trial summary
The purpose of this study is to determine whether nasal intubation assisted by GlideScope videolaryngoscopy is faster, easier, and less traumatic than nasal intubation with conventional direct laryngoscopy. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Nasal Intubation
- What is being tested?
- GlideScope videolaryngoscope
- Type of treatment
- Medical device
- How many people
- 70 participants
- Where
- 1 siteCanada
- Study dates
- Nov 2006to Sep 2007
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- any patient who is at least 18 years old
- patient requires nasal intubation for surgical indications
- operator has performed at least 10 prior GlideScope intubations (oral or nasal)
Who cannot join
- cervical spine abnormalities
- known difficult airway
- requires rapid sequence induction
- any other patient in whom the attending anesthesiologist believes usage of the GlideScope is contraindicated
Trial locations and contacts
1 site in 1 country.
About this study
The purpose of this study is to determine whether nasal intubation assisted by GlideScope videolaryngoscopy is faster, easier, and less traumatic than nasal intubation with conventional direct laryngoscopy.
- Conditions
- Nasal Intubation
- Being tested
- GlideScope videolaryngoscope
- Keywords
- GlideScope, videolaryngoscopy, intubation, nasal, nasotracheal, laryngoscopy, anesthesia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
GlideScope videolaryngoscopeDevice
What is being measured
The primary outcome is the main question the study is designed to answer.
time to intubation
Secondary outcomes (4)
ease of intubation (VAS)
incidence of trauma
number of failures
severity of patient sore throat on post-operative day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Nov 2006 (estimated)
- Study startNov 2006
- Primary completionSep 2007
- Study completionSep 2007
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Nasal IntubationStudies of the same condition, open and under way.
- More trials run by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Single blind
- Enrolment
- 70 participants (estimated)
Sponsor and investigators
- Lead sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Sponsor type
- University, hospital or other
- Collaborators
- London Health Sciences Centre
- Investigators
- Philip M Jones, MD, Principal investigator, London Health Sciences Centre
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00400972
- Sponsor's protocol ID
- R-06-467
- Other IDs
- HSREB 12719
- Status last verified
- Sep 2007
- First submitted
- 15 Nov 2006
- Last updated
- 29 Oct 2021
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 Oct 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of GlideScope Videolaryngoscopy to Direct Laryngoscopy for Nasal Intubation
- ClinicalTrials.gov ID
- NCT00400972
- Acronym / sponsor ID
- R-06-467
- Conditions
- Nasal Intubation
- Keywords
- GlideScope, videolaryngoscopy, intubation, nasal, nasotracheal, laryngoscopy, anesthesia
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 70 participants (estimated)
- Lead sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sUniversity, hospital or other
- Collaborators
- London Health Sciences Centre
- Study start
- Nov 2006
- Primary completion
- Sep 2007 (actual)
- Study completion
- Sep 2007 (actual)
- First posted
- 17 Nov 2006 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to determine whether nasal intubation assisted by GlideScope videolaryngoscopy is faster, easier, and less traumatic than nasal intubation with conventional direct laryngoscopy.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Single blind
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- any patient who is at least 18 years old
- patient requires nasal intubation for surgical indications
- operator has performed at least 10 prior GlideScope intubations (oral or nasal)
Key exclusion criteria (4 listed)
- cervical spine abnormalities
- known difficult airway
- requires rapid sequence induction
- any other patient in whom the attending anesthesiologist believes usage of the GlideScope is contraindicated
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| GlideScope videolaryngoscope | Device | – |
Primary outcome
time to intubation
4 secondary outcomes
ease of intubation (VAS)
incidence of trauma
number of failures
severity of patient sore throat on post-operative day 1
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Oct 2021.
Related trials for Nasal Intubation
RecruitingObservational study
Predicting High-Flow Nasal Oxygen Failure Within 72 Hours Using a Physiology-Informed Dual-Domain Model at 30 Minutes
Acute Respiratory Failure, Electrical Impedance Tomography (EIT)
Not yet recruiting
ASIGN Trial- Angulated Versus Standard Video-laryngoscope Blade in Nasal Intubation
Nasal Intubation
Recruiting
Comparison of Awake Tracheal Intubation Methods
Airway Management Assessment, Awake Endotracheal Intubation
Recruiting
SEALion: Study on Supplemental Oxygenation Via Nasal Cannula for Young Children During Intubation
Difficult Airway, Difficult Airway Intubation
Recruiting
High-flow Nasal Cannula Versus Conventional Oxygen During Awake Tracheal Intubation With Difficult Airways
Awake Tracheal Intubation, Difficult Airway
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Philip M Jones, MD principal investigator
London Health Sciences Centre
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing GlideScope videolaryngoscope in people with Nasal Intubation, run by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
time to intubation. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2021.